Super‑Shred (lipotropic blend)
A custom-mixed fat-burner cocktail given by injection, with carnitine and albuterol; it can be dangerous for the heart and is banned in sport.

DETAILED OVERVIEW
What is Super-Shred (lipotropic blend)?
Super-Shred (lipotropic blend) is a custom-mixed fat-burner cocktail given by injection. It combines five ingredients: L-carnitine, a trio that helps the liver handle fat (methionine, inositol and choline), ATP, albuterol (a drug that opens the airways) and vitamin B12. No approved product of this kind exists; it is made at home or through individual pharmacy compounding.
The idea is that carnitine helps burn fat and albuterol speeds up fat breakdown by producing heat. The evidence for fat loss is mostly for the individual ingredients, and there is no controlled study of the blend. The main risk comes from albuterol: it can cause a fast heartbeat, hand tremor, low potassium and strain on the heart. Because of albuterol it is banned in competitive sport. In home-made or grey-market mixes, purity and sterile production are not guaranteed, the real albuterol content may differ from the label, and an abscess can develop at the injection site. It cannot be used with heart rhythm disorders or high blood pressure, or during pregnancy and breastfeeding.
Type
Compounded injectable lipotropic fat-burner cocktail (5-component 'lipo shot')
Composition
L-carnitine, methionine, inositol, choline, ATP, albuterol and vitamin B12
Mechanism
Fatty-acid shuttle (carnitine) + hepatic lipotropics (MIC) + beta-2 thermogenic (albuterol) + cofactors (ATP, B12)
Administration
Subcutaneous / intramuscular injection (aqueous solution)
Legal status
No approved fixed-dose blend exists; compounded / grey-market. Albuterol beta-2 agonist is WADA-banned (oral/injectable). EU + HU: Rx components.
This stack contains the following peptides
MIC Blend (Methionine, Inositol, Choline)
ATP
B12 (cyanocobalamin)
No anecdote collected yet.
Data console
Lab data
Stephens FB, Constantin-Teodosiu D, Greenhaff PL. . New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol. 2007;581(Pt 2):431-444..
Koeth RA, Wang Z, Levison BS et al. . Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med. 2013;19(5):576-585..
Cazzola M, Page CP, Calzetta L, Matera MG. . Pharmacology and therapeutics of bronchodilators. Pharmacol Rev. 2012;64(3):450-504..
Kraemer WJ, Volek JS, French DN et al. . L-carnitine L-tartrate supplementation favorably affects markers of recovery from exercise stress. J Strength Cond Res. 2003;17(3):455-462..
Safety
Side effects, stop signs, contraindications
Side effects · 8
- Tachycardia and palpitations: the Albuterol beta-2 agonist effect raises heart rate and causes palpitations, especially at higher doses or combined with other stimulants.
- Hand tremor (fine shaking): beta-2 receptor stimulation causes a characteristic, dose-dependent skeletal-muscle tremor, most often in the hands.
- Hypokalaemia (low blood potassium): beta-2 activation shifts potassium into cells, which can cause muscle weakness and arrhythmia risk, especially alongside diuretics.
- Restlessness, anxiety, insomnia: the sympathomimetic effect of Albuterol can cause nervousness, inner tension and disturbed sleep.
- Headache and muscle cramps: a common beta-2 agonist side effect; the cramping can be aggravated in part by hypokalaemia.
- Injection-site reaction and sterility risk: with grey-market/compounded aqueous injectables purity and sterility are not guaranteed, so local pain, inflammation, abscess or infection can occur.
- Dose uncertainty (compounded mix): the actual Albuterol content can deviate significantly from the labelled amount, causing unpredictable cardiovascular load.
- L-Carnitine TMAO elevation: chronic carnitine intake can be converted by gut microbiota to TMAO, which has been linked over the long term to atherosclerosis risk (Koeth 2013).
Contraindications · 7
- Pre-existing tachyarrhythmia, atrial fibrillation or cardiomyopathy: the Albuterol beta-2 effect worsens the arrhythmia, an absolute contraindication.
- Untreated or severe hypertension (>140/90 mmHg): the sympathomimetic load further raises blood pressure.
- Hyperthyroidism / Graves disease: contraindicated due to heightened adrenergic sensitivity and arrhythmia risk.
- Pregnancy and breastfeeding: the beta-2 agonist crosses over and has tocolytic/cardiovascular effects; the compounded mix has no established safety.
- Concurrent beta-blocker or MAO-inhibitor therapy: a beta-blocker blocks the effect and may cause vasoconstriction, while with an MAO inhibitor there is a risk of hypertensive crisis and tachycardia.
- Combination with another beta-2 agonist/stimulant (clenbuterol, ECA stack, caffeine): additive cardiac stress and hypokalaemia, contraindicated.
- WADA-tested athletes: injectable/oral Albuterol beta-2 agonist use is prohibited in competition (only inhaled <1600 ug/24h is permitted).
Related Performance Compounds
Same therapeutic category
Studies
Related research and clinical findings
New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle
Stephens FB, Constantin-Teodosiu D, Greenhaff PL.
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Koeth RA, Wang Z, Levison BS et al.
Pharmacology and therapeutics of bronchodilators
Cazzola M, Page CP, Calzetta L, Matera MG.
L-carnitine L-tartrate supplementation favorably affects markers of recovery from exercise stress
Kraemer WJ, Volek JS, French DN et al.
Telegram
Have a question about Super‑Shred (lipotropic blend)?
Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.